- Other markets
- IG services
- Trading platforms
- IG analysis
No data available for this market
BRIEF: For the fiscal year ended 31 December 2014, Enzon Pharmaceuticals Inc revenues decreased 10% to $31.2M. Net income increased 59% to $28.8M. Revenues reflect Miscellaneous income decrease of 79% to $135K. Net income reflects General and administrative decrease of 73% to $2.4M (expense), Restructuring charges decrease from $4.8M (expense) to $0K, Research and development decrease from $2.7M (expense) to $0K.